equitysell

NCI

Trust-weighted public proof page for NCI. See which authors support it, which ticker theses it belongs to, and how thesis calls have performed.

Opportunity

90 / 100

Current score

-1.60

Thesis calls

Active decisions

Recent proof-backed thesis calls

Public preview of asset-level thesis calls linked to source content, observed prices, and outcomes.

COHERENT CORP.sec_filingsopen

The provided excerpt is only the cover/registrant-identification portion of Coherent Corp.’s (COHR) 10‑Q for the quarter ended 2026‑03‑31. It contains no financial statements, segment results, guidance, risk updates, liquidity/debt detail, or MD&A content, so it does not support a directional investment conclusion.

Mentioned: May 6, 2026, 4:10 PM EDTConviction: 80 / 100

View source

Source: COHR 10-Q report for 2026-03-31

COHERENT CORP.sec_filingsopen

This source is only the cover/header portion of Coherent Corp.’s Form 10-Q for the quarter ended Dec 31, 2025. It confirms the filing and listing (NYSE: COHR) but contains no financial statements, segment results, guidance, or risk-factor updates to assess fundamentals or derive tradable implications.

Mentioned: Feb 4, 2026, 4:06 PM ESTConviction: 80 / 100

View source

Source: COHR 10-Q report for 2025-12-31